Roundtable: Real-Time Clinical Trials: Redefining Data and Oversight

Session details:

The FDA’s push toward real-time clinical trials is shifting development from periodic reporting to continuous data flow. This roundtable will discuss what this means for trial design, data infrastructure, and regulatory engagement—and how sponsors can prepare for a more real-time, data-driven model.